Martedì, 23 Ottobre 2018

Italy bans Novartis flu vaccines amid side-effects probe


Rome, October 24 - Italian health authorities
called for the immediate suspension of several influenza
vaccinations on Wednesday produced by the pharmaceuticals
company Novartis.
The Italian Heath Ministry together with AIFA, a state
agency governing the local pharmaceuticals industry, is
investigating possible side effects of the vaccines, according
to a statement released by the ministry.
The banned pharmaceuticals include Novartis' Fluad,
Agrippal and several other injectable vaccines produced for the
Italian market.
"Citizens are asked not to buy or use any of these vaccines
until further notice", the ministry said in a statement.
The statement said that the measures are purely cautionary.
State body AIFA has "on the basis of the documentation
presented by the company, determined the need for a probe into
the quality and the safety of these products to determine
whether they can cause any unwanted side effects or collateral
reactions. Italy's Health Minister Renato Balduzzi is closely
monitoring the situation", the statement said.

© Riproduzione riservata

* Campi obbligatori

Immagine non superiore a 5Mb (Formati permessi: JPG, JPEG, PNG)
Video non superiore a 10Mb (Formati permessi: MP4, MOV, M4V)


Accedi con il tuo account Facebook

Login con

Login con Facebook
  • Seguici su